No Data
No Data
Biovie Opens Patient Enrollment For Phase 2 Sunrise-Pd Clinical Trial Evaluating The Safety And Efficacy Of Bezisterim On Motor And Non-Motor Symptoms In Patients With Parkinson's Disease Who Haven't Been Treated With Carbidopa/Levodopa. Topline Data...
Express News | BioVie Inc - Topline Data Expected in Late 2025 or Early 2026
Express News | BioVie Initiates Sunrise-Pd Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease With First Patient Enrolled
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team With Kevin Harrington and Tony Raynor, and EXoZymes Vice...
BioVie to Host KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and Its ADDRESS-LC Trial on April 10, 2025
New to The Street's FOX Business Show #638 Spotlights Visionary CEOs and Breakthrough Innovations Across Health, AI, and Insurance Featuring BioVie CEO Cuong Do, Roadzen CEO Rohan Malhotra, Lou Basenese's The Big Skinny on EXoZymes, and Banzai CEO Joe...